The Philippines MRI Market was valued at $14.61 Mn in 2023 and is predicted to grow at a CAGR of 7% from 2023 to 2030, to $23.46 Mn by 2030. The key drivers of this industry include increasing awareness, rising burden of chronic diseases, and government initiatives. The key players in the industry are GE Healthcare, Esaote, and Hitachi Medical Corporation, Siemens Healthineers among others.
Mexico Dental Implant Market was valued at $74.80 Mn in 2023 and is predicted to grow at a CAGR of 10.05% from 2023 to 2030, to $146.30 Mn by 2030. The key drivers of this industry include growing demand for aesthetics, growing dental awareness, medical tourism potential, and improved dental infrastructure. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
The China Hypersomnia Therapeutics Market was valued at $59.80 Mn in 2023 and is predicted to grow at a CAGR of 2.50% from 2023 to 2030, to $71.08 Mn by 2030. The key drivers of this industry include increasing awareness, lifestyle changes, expanding geriatric population, and early detection. The key players in the industry are Teva, Takeda, Jiangsu Hengrui Medicine Co., Ltd., Shanghai Junshi Biosciences Co., Ltd., and Jazz Pharmaceuticals among others.
The Singapore MRI Market was valued at $7.97 Mn in 2023 and is predicted to grow at a CAGR of 7.1% from 2023 to 2030, to $12.88 Mn by 2030. The key drivers of this industry include the rise in geriatric population, increasing demand for advanced imaging technologies, and expanding healthcare spending. The key players in the industry are GE Healthcare, Koninklijke Philips NV, Mindray Medical International, and Bruker among others.
France Dental Implant Market was valued at $137.20 Mn in 2023 and is predicted to grow at a CAGR of 8.8% from 2023 to 2030, to $247.70 Mn by 2030. The key drivers of this industry include growing demand for aesthetics, growing dental awareness, government initiatives, and improved dental infrastructure. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
The Indonesia Hypersomnia Therapeutics Market was valued at $84.18 Mn in 2023 and is predicted to grow at a CAGR of 2.70% from 2023 to 2030, to $101.44 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Kalbe Farma, Dexca Medica, Teva, Takeda, and Indofarma among others.
The Brazil Conjunctivitis Therapeutics Market was valued at $103 Mn in 2022 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to $168 Mn by 2030. The key drivers of this industry include the rising prevalence of conjunctivitis, expanding healthcare accessibility, and expanding pharmaceutical landscape in the industry. The industry is primarily dominated by players such as Novartis, Pfizer, Bausch & Lomb, Sanofi, Santen, and Allergan among others.
The Vietnam MRI Market was valued at $33.20 Mn in 2023 and is predicted to grow at a CAGR of 6.73% from 2023 to 2030, to $52.38 Mn by 2030. The key drivers of this industry include increasing prevalence of chronic diseases, increase healthcare expenditure, and focus on early detection. The key players in the industry are Siemens Healthineers, Neusoft Medical Systems Vietnam, and IBM Watson Health among others.
Germany Dental Implant Market was valued at $182.60 Mn in 2023 and is predicted to grow at a CAGR of 8% from 2023 to 2030, to $313 Mn by 2030. The key drivers of this industry include growing demand for aesthetics, growing dental awareness, an aging population, and technological advancements. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
The Japan Hypersomnia Therapeutics Market was valued at $63.25 Mn in 2023 and is predicted to grow at a CAGR of 3.5% from 2023 to 2030, to $80.47 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Aculys Pharma Inc., Teva, Takeda, and Eisai among others.
The Egypt MRI Market was valued at $18.59 Mn in 2023 and is predicted to grow at a CAGR of 8% from 2023 to 2030, to $31.86 Mn by 2030. The key drivers of this industry include the increasing prevalence of chronic diseases, improved quality of healthcare services, and emphasis on research and development. The key players in the industry are GE Healthcare, Esaote, Philips Healthcare Egypt, and Fujifilm Healthcare among others.
Spain Dental Implant Market was valued at $96.30 Mn in 2023 and is predicted to grow at a CAGR of 8.8% from 2023 to 2030, to $173.80 Mn by 2030. The key drivers of this industry include growing demand for aesthetics, growing dental awareness, an aging population, and improved dental infrastructure. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
The Malaysia Hypersomnia Therapeutics Market was valued at $44.39 Mn in 2023 and is predicted to grow at a CAGR of 3.50% from 2023 to 2030, to $56.48 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Jazz Pharmaceuticals, Pfizer, Teva Pharmaceuticals, and GSK among others.
The South Africa MRI Market was valued at $43.16 Mn in 2023 and is predicted to grow at a CAGR of 7.73% from 2023 to 2030, to $72.68 Mn by 2030. The key drivers of this industry include increasing prevalence of chronic diseases, advancements in MRI, and developing healthcare infrastructure. The key players in the industry are Siemens AG, Koninklijke Philips N.V., Parklane Radiology, and Shimadzu South Africa among others.
UK Dental Implant Market was valued at $2095.80 Mn in 2023 and is predicted to grow at a CAGR of 7.8% from 2023 to 2030, to $3545.50 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, a growing aging population, growing awareness of benefits, and improved dental technology. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
The Singapore Hypersomnia Therapeutics Market was valued at $39.10 Mn in 2023 and is predicted to grow at a CAGR of 6% from 2023 to 2030, to $58.79 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Pfizer, Sanofi, Sphaera Pharma, and Raffles Medical among others.
The Egypt Conjunctivitis Therapeutics Market was valued at $11 Mn in 2022 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $20 Mn by 2030. The key drivers of this industry include the rising prevalence of conjunctivitis, expanding healthcare infrastructure, and the evolving treatment landscape. The industry is primarily dominated by players such as Allergan, Sun Pharma, Novartis, Sirion, Boehringer Ingelheim, Pfizer, and Auven among others.
The Kenya MRI Market was valued at $4.65 Mn in 2023 and is predicted to grow at a CAGR of 7.6% from 2023 to 2030, to $7.76 Mn by 2030. The key drivers of this industry include the growing prevalence of chronic diseases, government initiatives, and growing awareness of early detection. The key players in the industry are Siemens Healthineers, Neusoft Medical Systems, Hitachi Healthcare, and GE Healthcare among others.
China Dental Implant Market was valued at $401.10 Mn in 2023 and is predicted to grow at a CAGR of 11.3% from 2023 to 2030, to $848.70 Mn by 2030. The key drivers of this industry include growing demand for aesthetics, growing dental awareness, and technological advancements. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
The Philippines Hypersomnia Therapeutics Market was valued at $11.50 Mn in 2023 and is predicted to grow at a CAGR of 5.50% from 2023 to 2030, to $16.73 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Novartis, Pfizer, Johnson & Johnson, and GSK among others.
The India MRI Market was valued at $120.76 Mn in 2023 and is predicted to grow at a CAGR of 9.5% from 2023 to 2030, to $227.93 Mn by 2030. The key drivers of this industry the growing prevalence of chronic diseases, advanced MRI systems, and expanding healthcare infrastructure. The key players in the industry are Siemens Healthcare, Neusoft India, Voxelgrids Innovations, and Philips India among others.
Indonesia Dental Implant Market was valued at $29.90 Mn in 2023 and is predicted to grow at a CAGR of 9.8% from 2023 to 2030, to $57.60 Mn by 2030. The key drivers of this industry include growing demand for aesthetics, growing dental awareness, and technological advancements. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
The Vietnam Hypersomnia Therapeutics Market was valued at $6.44 Mn in 2023 and is predicted to grow at a CAGR of 6% from 2023 to 2030, to $9.68 Mn by 2030. The key drivers of this industry include increasing awareness, lifestyle changes, expanding geriatric population, and early detection. The key players in the industry are Teva, Jazz Pharmaceuticals, ImexPharma, Sanofi, and Pfizer among others.
The Germany Conjunctivitis Therapeutics Market was valued at $150 Mn in 2022 and is predicted to grow at a CAGR of 3.6% from 2023 to 2030, to $199 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of conjunctivitis, favorable reimbursement conditions, and the development of new drugs in the industry. The industry is primarily dominated by players such as Allergan, Pfizer, Bausch & Lomb, Auven, and Santen among others.
Japan Dental Implant Market was valued at $310.20 Mn in 2023 and is predicted to grow at a CAGR of 10.3% from 2023 to 2030, to $616.10 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, an aging population, advanced dental technology, and high dental awareness. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.